Outlook TherapeuticsOTLK 
$1.443.24%24h
3.24%24h
Global rank13383
Market cap$359.00M
Change 7d-3.04%
YTD Performance256.08%
SP500 benchmarkOutperform
P/E-5.98
P/S0
Revenue$0
Earnings-$58.98M
Dividend yield-
Main Sector
Healthcare
Category
EPS for Outlook Therapeutics (OTLK)
Outlook Therapeutics has an EPS of $-0.24. In 2022, the company made an earnings per share (EPS) of $-0.31. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for OTLK
-
Value:-
EPS history for Outlook Therapeutics from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$0.24 | -22.58% |
| 2022 | -$0.31 | -11.43% |
| 2021 | -$0.35 | -47.76% |
| 2020 | -$0.67 | - |
View the highest EPS stocks
